Mr. Derek Tierney:

I will make some remarks. During the electives project every option will be taken to fast track in parallel. As regards the Covid-19 context, in fairness to the derogations supplied in public procurement and planning, the scale we are now bringing forward means we will have to engage in international markets in terms of the choice for design and build and that would always be the threat. If we look to work outside public procurement there is a competition threat. Post-Covid-19 we are regulated by public procurement guidance which sets out minimum statutory timeframes, and we are regulated by proper planning consent, again which is regulated by minimum statutory requirements. That is not to say we will not look at every opportunity to learn from Covid-19 to see how to apply this. That is what is ahead of us now in terms of working that detail out, standing up design teams, standing up clinical design, and a central design authority that will bring a standardisation both to the models of care we are looking to separate but also the construction technology that will apply. We are already looking at what manufacturing for construction looks like, modular builds and pre-fab off-site; they will all be brought into focus on this programme.